NantWorks

Billionaire biotech entrepreneur Patrick Soon-Shiong's NantWorks has invested in new funding rounds for Prolific Machines and Multiply Labs, two startups aiming to disrupt biopharmaceutical manufacturing. Prolific Machines works on light-based cell culture control, while Multiply Labs develops robotics for drug production, and the investments signal growing interest in technology-driven manufacturing innovation.